DK159770C - Analogifremgangsmaade til fremstilling af etherforbindelser eller farmakologisk acceptable salte deraf, samt ether-mellemprodukter til anvendelse som udgangsforbindelser ved fremgangsmaaden - Google Patents
Analogifremgangsmaade til fremstilling af etherforbindelser eller farmakologisk acceptable salte deraf, samt ether-mellemprodukter til anvendelse som udgangsforbindelser ved fremgangsmaadenInfo
- Publication number
- DK159770C DK159770C DK279780A DK279780A DK159770C DK 159770 C DK159770 C DK 159770C DK 279780 A DK279780 A DK 279780A DK 279780 A DK279780 A DK 279780A DK 159770 C DK159770 C DK 159770C
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- ether
- substances
- preparation
- acceptable salts
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/30—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/74—Unsaturated compounds containing —CHO groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7922781 | 1979-06-29 | ||
| GB7922781 | 1979-06-29 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK279780A DK279780A (da) | 1980-12-30 |
| DK159770B DK159770B (da) | 1990-12-03 |
| DK159770C true DK159770C (da) | 1991-04-22 |
Family
ID=10506199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK279780A DK159770C (da) | 1979-06-29 | 1980-06-27 | Analogifremgangsmaade til fremstilling af etherforbindelser eller farmakologisk acceptable salte deraf, samt ether-mellemprodukter til anvendelse som udgangsforbindelser ved fremgangsmaaden |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4410537A (member.php) |
| EP (1) | EP0022229B1 (member.php) |
| JP (1) | JPS5649335A (member.php) |
| KR (2) | KR850000073B1 (member.php) |
| AU (1) | AU545274B2 (member.php) |
| DE (1) | DE3061269D1 (member.php) |
| DK (1) | DK159770C (member.php) |
| FI (1) | FI71929C (member.php) |
| GB (1) | GB2053218B (member.php) |
| GR (1) | GR68748B (member.php) |
| HU (1) | HU190774B (member.php) |
| IL (1) | IL60422A (member.php) |
| IT (1) | IT1133025B (member.php) |
| MW (1) | MW2380A1 (member.php) |
| OA (1) | OA06699A (member.php) |
| ZA (1) | ZA803880B (member.php) |
| ZM (1) | ZM5780A1 (member.php) |
| ZW (1) | ZW14480A1 (member.php) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA818741B (en) * | 1980-12-18 | 1983-07-27 | Wellcome Found | Pharmaceutical compounds,preparation,use and intermediates therefor and their preparation |
| GB8606913D0 (en) * | 1986-03-20 | 1986-04-23 | Hider R C | Treatment of sickle cell disease |
| US6083522A (en) | 1997-01-09 | 2000-07-04 | Neucoll, Inc. | Devices for tissue repair and methods for preparation and use thereof |
| US7129274B1 (en) | 1999-11-05 | 2006-10-31 | Emisphere Technologies Inc. | Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| US7279597B1 (en) | 1999-11-05 | 2007-10-09 | Emisphere Technologies, Inc. | Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| JP5117658B2 (ja) * | 1999-11-05 | 2013-01-16 | エミスフェアー・テクノロジーズ・インク | フェノキシカルボン酸化合物及び活性剤を送達するための組成物 |
| RU2300516C2 (ru) * | 1999-11-05 | 2007-06-10 | Эмисфере Текнолоджиз, Инк. | Соединения феноксикарбоновой кислоты и композиции для доставки активных веществ |
| JP2003528068A (ja) * | 2000-03-17 | 2003-09-24 | コリクサ コーポレイション | 新規両親媒性アルデヒドならびにアジュバントおよび免疫エフェクターとしてのそれらの使用 |
| US8246969B2 (en) | 2001-11-16 | 2012-08-21 | Skinmedica, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
| WO2012094638A1 (en) | 2011-01-07 | 2012-07-12 | Skinmedica, Inc. | Melanin modification compositions and methods of use |
| US9012450B2 (en) | 2011-12-28 | 2015-04-21 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| HUE035069T2 (en) * | 2011-12-28 | 2018-05-02 | Global Blood Therapeutics Inc | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| CA2902711C (en) | 2013-03-15 | 2021-07-06 | Global Blood Therapeutics, Inc. | Substituted pyridinyl-6-methoxy-2-hydroxybenzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin |
| ES2993155T3 (en) | 2013-03-15 | 2024-12-23 | Global Blood Therapeutics Inc | Compounds and uses thereof for the modulation of hemoglobin |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| KR102280614B1 (ko) * | 2013-03-15 | 2021-07-21 | 글로벌 블러드 테라퓨틱스, 인크. | 헤모글로빈 조정을 위한 화합물 및 이의 용도 |
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| WO2014145040A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| WO2015027067A2 (en) * | 2013-08-23 | 2015-02-26 | Virginia Commonwealth University | Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease |
| EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| SG10201911662YA (en) | 2014-02-07 | 2020-02-27 | Global Blood Therapeutics Inc | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| AU2016229294B2 (en) | 2015-03-06 | 2021-11-04 | Beyondspring Pharmaceuticals, Inc. | Method of treating cancer associated with a RAS mutation |
| MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
| HUE072191T2 (hu) | 2015-12-04 | 2025-10-28 | Global Blood Therapeutics Inc | A 2-hidoxi-6-((2-(1-izopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehid adagolási rendje |
| CN108778267A (zh) * | 2016-02-08 | 2018-11-09 | 万春药业公司 | 包含妥卡雷琐或其类似物的组合物 |
| AR108435A1 (es) | 2016-05-12 | 2018-08-22 | Global Blood Therapeutics Inc | Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído |
| RU2760348C2 (ru) | 2016-06-06 | 2021-11-24 | Бейондспринг Фармасьютикалс, Инк. | Способ уменьшения нейтропении |
| TW202332423A (zh) | 2016-10-12 | 2023-08-16 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
| CN110431135A (zh) | 2017-01-06 | 2019-11-08 | 大连万春布林医药有限公司 | 微管蛋白结合化合物及其治疗用途 |
| US11400086B2 (en) | 2017-02-01 | 2022-08-02 | Beyondspring Pharmaceuticals, Inc. | Method of reducing chemotherapy-induced neutropenia |
| US11401241B2 (en) * | 2018-03-22 | 2022-08-02 | Virginia Commonwealth University | Aromatic aldehydes with sustained and enhanced in vitro and in vivo pharmacologic activity to treat sickle cell disease |
| ES2966707T3 (es) | 2018-10-01 | 2024-04-23 | Global Blood Therapeutics Inc | Moduladores de la hemoglobina para el tratamiento de la drepanocitosis |
| HRP20220295T1 (hr) | 2018-11-19 | 2022-05-13 | Global Blood Therapeutics, Inc. | Spojevi 2-formil-3-hidroksifeniloksimetila koji mogu modulirati hemoglobin |
| US12479816B2 (en) | 2019-02-08 | 2025-11-25 | University of Pittsburgh—of the Commonwealth System of Higher Education | 20-HETE formation inhibitors |
| JP2024513505A (ja) | 2021-04-09 | 2024-03-25 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | 腫瘍を治療するための組成物及び方法 |
| AU2023376662B2 (en) * | 2022-11-07 | 2025-06-05 | Children's Hospital Of Philadelphia (Chop) | Benzaldehyde compounds with direct polymer destabilizing effects to treat sickle cell disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL236575A (member.php) * | 1958-04-30 | |||
| CH543472A (fr) * | 1969-01-31 | 1973-10-31 | Orchimed Sa | Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques |
| DE2209128C3 (de) | 1971-03-05 | 1981-10-22 | CIBA-GEIGY AG, 4002 Basel | Bis-Stilbenverbindungen, Verfahren zu deren Herstellung und deren Verwendung als optische Aufheller |
| CH550776A (de) | 1971-03-05 | 1974-06-28 | Ciba Geigy Ag | Herstellung neuer bis-stilbenverbindungen. |
| GB1511645A (en) | 1974-05-31 | 1978-05-24 | Univ Ife | Sickle cell anaemia treatment |
| US4137309A (en) * | 1976-10-14 | 1979-01-30 | The Procter & Gamble Company | Therapeutic treatment |
-
1980
- 1980-06-27 GR GR62311A patent/GR68748B/el unknown
- 1980-06-27 KR KR1019800002541A patent/KR850000073B1/ko not_active Expired
- 1980-06-27 DK DK279780A patent/DK159770C/da not_active IP Right Cessation
- 1980-06-27 DE DE8080103657T patent/DE3061269D1/de not_active Expired
- 1980-06-27 AU AU59697/80A patent/AU545274B2/en not_active Ceased
- 1980-06-27 EP EP80103657A patent/EP0022229B1/en not_active Expired
- 1980-06-27 IT IT49108/80A patent/IT1133025B/it active
- 1980-06-27 JP JP8764580A patent/JPS5649335A/ja active Granted
- 1980-06-27 ZA ZA00803880A patent/ZA803880B/xx unknown
- 1980-06-27 IL IL60422A patent/IL60422A/xx not_active IP Right Cessation
- 1980-06-27 GB GB8021219A patent/GB2053218B/en not_active Expired
- 1980-06-27 FI FI802052A patent/FI71929C/fi not_active IP Right Cessation
- 1980-06-27 MW MW23/80A patent/MW2380A1/xx unknown
- 1980-06-27 HU HU801601A patent/HU190774B/hu not_active IP Right Cessation
- 1980-06-27 ZW ZW144/80A patent/ZW14480A1/xx unknown
- 1980-06-27 ZM ZM57/80A patent/ZM5780A1/xx unknown
- 1980-08-09 OA OA57193A patent/OA06699A/xx unknown
-
1981
- 1981-06-09 US US06/271,950 patent/US4410537A/en not_active Expired - Lifetime
-
1984
- 1984-03-13 KR KR1019840001263A patent/KR850000072B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| MW2380A1 (en) | 1982-03-10 |
| ZA803880B (en) | 1982-02-24 |
| DE3061269D1 (en) | 1983-01-13 |
| EP0022229B1 (en) | 1982-12-08 |
| IT1133025B (it) | 1986-07-09 |
| US4410537A (en) | 1983-10-18 |
| JPS5649335A (en) | 1981-05-02 |
| AU5969780A (en) | 1981-01-08 |
| EP0022229A1 (en) | 1981-01-14 |
| HU190774B (en) | 1986-11-28 |
| KR850000073B1 (ko) | 1985-02-18 |
| JPH0154339B2 (member.php) | 1989-11-17 |
| DK279780A (da) | 1980-12-30 |
| FI71929C (fi) | 1987-03-09 |
| IT8049108A0 (it) | 1980-06-27 |
| GR68748B (member.php) | 1982-02-16 |
| ZW14480A1 (en) | 1982-03-17 |
| OA06699A (fr) | 1982-05-31 |
| IL60422A0 (en) | 1980-09-16 |
| KR840004668A (ko) | 1984-10-22 |
| FI71929B (fi) | 1986-11-28 |
| AU545274B2 (en) | 1985-07-11 |
| KR850000072B1 (ko) | 1985-02-18 |
| IL60422A (en) | 1984-06-29 |
| KR830002693A (ko) | 1983-05-30 |
| GB2053218B (en) | 1984-01-25 |
| FI802052A7 (fi) | 1980-12-30 |
| ZM5780A1 (en) | 1983-11-21 |
| GB2053218A (en) | 1981-02-04 |
| DK159770B (da) | 1990-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK159770C (da) | Analogifremgangsmaade til fremstilling af etherforbindelser eller farmakologisk acceptable salte deraf, samt ether-mellemprodukter til anvendelse som udgangsforbindelser ved fremgangsmaaden | |
| DK160939C (da) | Analogifremgangsmaade til fremstilling af benzisothiazol- og benzisoxazolpiperazinderivater, samt mellemprodukter til anvendelse ved fremgangsmaaden | |
| DK15279A (da) | Fremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf | |
| DK148260C (da) | Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf | |
| DK503080A (da) | Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf | |
| DK419283A (da) | Alkoholsubstituerede amider, fremgangsmaade til fremstilling heraf samt anvendelse ved fremstilling af stoebebare polyurethanelastomerer | |
| DK273479A (da) | Fremgangsmaade til fremstilling af 5-phenylpyrazol-forbindelser eller salte deraf | |
| DK160561C (da) | Analogifremgangsmaade til fremstilling af 3-aminopregn-5-enderivater eller salte deraf | |
| DK341281A (da) | Fremgangsmaade til fremstilling af 3,3-dialkyldenzodiazepinderivater eller syreadditionssalte deraf samt ved fremgangsmaaden som mellemprodukter anvendelige forbindelrser | |
| DK159427C (da) | Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf | |
| DK118482A (da) | Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf | |
| DK76578A (da) | Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf | |
| DK27078A (da) | Fremgangsmaade til fremstilling af imidazoquinoliner eller salte deraf | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK324979A (da) | Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf | |
| DK152650C (da) | Analogifremgangsmaade til fremstilling af 5-substituerede oxazolidin-2,4-dioner eller farmaceutisk acceptable salte deraf og carboximidat-forbindelser til anvendelse som udgangsmaterialer ved fremgangsmaaden | |
| DK157024C (da) | Analogifremgangsmaade til fremstilling af 4-substituerede imidazooe1,2-aaaquinoxaliner samt 1-(2-acylaminophenyl)imidazoler til anvendelse som udgangsmaterialer ved fremgangsmaaden | |
| DK157538C (da) | Analogifremgangsmaade til fremstilling af heterocycliske phenoxyaminer samt 1-cyclohexenylmethyl-pyrrolidiner til anvendelse som mellemprodukt ved fremgangsmaaden | |
| DK511878A (da) | Fremgangsmaade til fremstilling af imidazobenzoazepiner eller salte deraf | |
| DK232777A (da) | Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf | |
| DK426980A (da) | Fremgangsmaade til fremstilling af quinazolinderivater eller salte deraf samt ved fremgangsmaaden anvendelige mellemprodukter | |
| DK232677A (da) | Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf | |
| DK115379A (da) | Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf | |
| DK57778A (da) | Fremgangsmaade til fremstilling af 1,3-disubstitueret urinstof eller 2-thioruinstof | |
| DK150206C (da) | Analogifremgangsmaade til fremstilling af lrf-analoge nona- eller decapeptidamider eller ikke-toksiske salte deraf og nona- eller decapeptidderivater til anvendelse som udgangsforbindelser ved fremgangsmaaden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |